Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Caitlin E. Cox

December 12, 2017

News Daily News

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

L.A. McKeown

November 21, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

Presentation

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

October 05, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Daily News

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

Todd Neale

July 24, 2017

News Daily News

ECGs Ordered After One in Five Annual Health Exams

Shelley Wood

July 13, 2017

News Daily News

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

Yael L. Maxwell

July 12, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Daily News

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

Caitlin E. Cox

May 08, 2017

News Conference News ACC 2017

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

Yael L. Maxwell

March 17, 2017

News Daily News

Putting Radiation Protection to the Test: Caps and Glasses Fall Short

L.A. McKeown

March 06, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

News Daily News

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Shelley Wood

February 28, 2017

News Daily News

E-Cigarettes May Increase CV Disease Risk Just Like the Real Thing

L.A. McKeown

February 03, 2017

Advertisement

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

ECGs Ordered After One in Five Annual Health Exams

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

Putting Radiation Protection to the Test: Caps and Glasses Fall Short

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

E-Cigarettes May Increase CV Disease Risk Just Like the Real Thing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content